About BioXpress Therapeutics

BioXpress Therapeutics SA is a privately held biotechnology company committed to developing high quality and cost-competitive biosimilars for unmet need indications such as cancer, inflammation and autoimmunity. Headquartered in Geneva, Switzerland, BioXpress Therapeutics business is focused on developing unbranded monoclonal antibody (MAb and MAb-like) biosimilar under strict European Medicines Agency (EMA) guidelines.

Facts about BioXpress Therapeutics
  • Founding: 2008
  • Focus : Service
  • Industry : Biotechnology

Product portfolio of BioXpress Therapeutics

Here you will find BioXpress Therapeutics, SA